Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 779
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
for
Cigarette Smoking-Related Carcinoma
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 21 - 55
Code: NCT06816459
Early Phase 1, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for
Adjustment Disorder
Location: Buffalo NY, Cleveland OH, Novi MI, Ann Arbor MI,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07002034
Phase 2, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Buffalo NY, Canton OH, Philadelphia PA, Bethesda MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase 2, Recruiting
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT06434064
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
for
Non-Hodgkin Lymphoma Refractory/ Relapsed,
Location: Buffalo NY, New York NY, Nashville TN, St Louis MO,
Sponsor: LTZ Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07121946
Phase 1, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Buffalo NY, New York NY, New Hyde Park NY, Lebanon NH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06997029
Phase 1, Recruiting
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
for
Ovarian Cancer Recurrent, Ovarian Cancer,
Location: Buffalo NY, Detroit MI, Minneapolis MN, Houston TX
Sponsor: Outpace Bio, Inc.
Sex: Female
Age: 18+
Code: NCT07030907
Phase 1, Recruiting
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
for
Graft Vs Host Disease, Vitamin A Deficiency,
Location: Buffalo NY, Columbus OH, Tampa FL
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 18+
Code: NCT06450925
Phase 2, Recruiting
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT07017829
Phase 2, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer